Prescribing Safety · Medication Safety in Pregnancy
The risks of selective serotonin reuptake inhibitor use in infertile women: a review of the impact on fertility, pregnancy, neonatal health and beyond
Domar AD et al., 2013
851 works
Therapeutics
The medication classes used in restorative care, with their mechanisms, monitoring, and evidence.
In Therapeutics
851 works
Hormonal Agents · Progesterone and Progestins
Progesterone use to reverse the effects of mifepristone
Delgado G et al., 2012
Emerging Therapies · Platelet-Rich Plasma
Using platelet-rich plasma for the treatment of symptomatic cervical ectopy
Hua X et al., 2012
Metabolic and Endocrine Agents · Insulin Sensitizing Agents
Effects of metformin use in pregnant patients with polycystic ovary syndrome
Kumar P et al., 2012
Supplements and Botanicals · Vitamins and Minerals
1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model
Halder SK et al., 2012
Metabolic and Endocrine Agents · Insulin Sensitizing Agents
Medical management of metabolic dysfunction in PCOS
Duleba AJ, 2012
Hormonal Agents · Estrogen Preparations
Significant Risks of Oral Contraceptives (OCPs): Why This Drug Class Should Not Be Included in a Preventive Care Mandate
Peck R et al., 2012
Hormonal Agents · Progesterone and Progestins
Diagnosis and management of catamenial seizures: a review
Verrotti A et al., 2012
Prescribing Safety · Medication Safety in Pregnancy
Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects
Anderka M et al., 2012
Supplements and Botanicals · Herbal and Botanical Products
Ethnobiology and Ethnopharmacology of Lepidium meyenii (Maca), a Plant from the Peruvian Highlands
Gonzales GF, 2012
Hormonal Agents · Estrogen Preparations
Effect of oral contraceptive therapy on homocysteine and C-reactive protein levels in women: an observational study
Norouzi V et al., 2011
Metabolic and Endocrine Agents · Insulin Sensitizing Agents
Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome
Oner G et al., 2011
Hormonal Agents · Androgens and DHEA
[Intracrinology and dehydroepiandrosterone--a new perspective for the use of androgens in hormone replacement therapy in postmenopausal women]
Perzyło K et al., 2011
Metabolic and Endocrine Agents · Insulin Sensitizing Agents
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes
Corrado F et al., 2011
Hormonal Agents · Estrogen Preparations
Bioidentical hormone therapy
Files JA et al., 2011
Anti-Infective and Anti-Inflammatory Agents · Immune Modulating Agents
Honey: its medicinal property and antibacterial activity
Mandal MD et al., 2011
Ovulation Agents · Dopamine Agonists
Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia
Gómez R et al., 2011
Prescribing Safety · Medication Safety in Pregnancy
Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial
Koren G et al., 2010
Hormonal Agents · Androgens and DHEA
Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS)
Gleicher N et al., 2010
Supplements and Botanicals · Herbal and Botanical Products
Maca (L. meyenii) for improving sexual function: a systematic review
Shin BC et al., 2010
Hormonal Agents · Progesterone and Progestins
Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy
Kalyan S et al., 2010
Supplements and Botanicals · Antioxidant Supplements
Endometrial growth and uterine blood flow: a pilot study for improving endometrial thickness in the patients with a thin endometrium
Takasaki A et al., 2010
Hormonal Agents · Progesterone and Progestins
Community pharmacists' therapeutic recommendations for heavy flow, androgen excess, fragility fractures and night sweats in menstruating women
Marks M et al., 2010
Hormonal Agents · Progesterone and Progestins
ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives
ACOG, 2010
Emerging Therapies · Low-Dose Naltrexone
Low dose naltrexone: side effects and efficacy in gastrointestinal disorders
Ploesser J et al., 2010
Hormonal Agents · Estrogen Preparations
Oral contraceptive pill for primary dysmenorrhoea
Wong CL et al., 2009
Hormonal Agents · Androgens and DHEA
Effect of vardenafil on endothelial progenitor cells in hypogonadotrophic hypogonadal patients: role of testosterone treatment
Foresta C et al., 2009
Prescribing Safety · Off-Label Prescribing
Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy
Lin G et al., 2009
Supplements and Botanicals · Herbal and Botanical Products
Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea
Ozgoli G et al., 2009
Supplements and Botanicals · Antioxidant Supplements
N-acetyl cysteine for treatment of recurrent unexplained pregnancy loss
Amin AF et al., 2008
Hormonal Agents · Gonadotropins
Follicle-stimulating hormone treatment of male infertility
Foresta C et al., 2008
Hormonal Agents · Progesterone and Progestins
No justification for using IUD to treat menorrhagia
Raviele KM, 2008
Hormonal Agents · Androgens and DHEA
Effects of testosterone on antioxidant systems in male secondary hypogonadism
Mancini A et al., 2008
Hormonal Agents · Progesterone and Progestins
Progesterone administration modulates TLRs/NF-kappaB signaling pathway in rat brain after cortical contusion
Chen G et al., 2008
Hormonal Agents · Progesterone and Progestins
Treatment of menorrhagia
Apgar BS et al., 2007
Metabolic and Endocrine Agents · Insulin Sensitizing Agents
Metformin reduces abortion in pregnant women with polycystic ovary syndrome
Khattab S et al., 2006
Emerging Therapies · Low-Dose Naltrexone
Low-Dose Naltreoxone for the Treatment of Irritable Bowel Syndrome: A Pilot Study
Kariv R et al., 2006
Supplements and Botanicals · Vitamins and Minerals
The case against ergocalciferol (vitamin D2) as a vitamin supplement
Houghton LA et al., 2006
Hormonal Agents · Androgens and DHEA
Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines
Fischer TW et al., 2006
Hormonal Agents · Androgens and DHEA
Melatonin induces apoptosis in human neuroblastoma cancer cells
García-Santos G et al., 2006
Metabolic and Endocrine Agents · Insulin Sensitizing Agents
Normalization of hyperinsulinemia by chronic opioid receptor blockade in hyperandrogenemic women
Hadziomerovic D et al., 2006
Metabolic and Endocrine Agents · Thyroid Replacement
Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications
Negro R et al., 2006
Anti-Infective and Anti-Inflammatory Agents · Nonsteroidal Anti-Inflammatory Drugs
Preventing copper intrauterine device removals due to side effects among first-time users: randomized trial to study the effect of prophylactic ibuprofen
Hubacher D et al., 2006
Hormonal Agents · Progesterone and Progestins
Over-the-counter progesterone cream produces significant drug exposure compared to a food and drug administration-approved oral progesterone product
Hermann AC et al., 2005
Anti-Infective and Anti-Inflammatory Agents · Immune Modulating Agents
Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant
Empson M et al., 2005
Hormonal Agents · Androgens and DHEA
Erectile dysfunction in aging men: testosterone role in therapeutic protocols
Caretta N et al., 2005
Supplements and Botanicals · Vitamins and Minerals
Vitamin D2 is much less effective than vitamin D3 in humans
Armas LA et al., 2004
Prescribing Safety · Medication Safety in Pregnancy
The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study
Einarson A et al., 2004
Hormonal Agents · Androgens and DHEA
Role of androgens in erectile function
Foresta C et al., 2004
Ovulation Agents · Aromatase Inhibitors
Aromatase inhibitors in ovulation induction
Mitwally MF et al., 2004
Hormonal Agents · Progesterone and Progestins
Chapter 27: Cooperative Progesterone and Estrogen Replacement
Hilgers TW, 2004 Book chapter
Hormonal Agents · Progesterone and Progestins
Chapter 37: Role of Compounding Pharmacist
Hilgers TW et al., 2004 Book chapter
Hormonal Agents · Gonadotropins
[Influence of GnRH analogue on the intensification of endometriosis symptoms and infertility treatment]
Skrzypulec V et al., 2004
Ovulation Agents · Aromatase Inhibitors
Ovulation induction in women with infertility: a new indication for aromatase inhibitors
Bulun SE, 2003
Hormonal Agents · Progesterone and Progestins
Classification and pharmacology of progestins
Schindler AE et al., 2003
Ovulation Agents · Selective Estrogen Receptor Modulators
Use of clomiphene citrate in women
Practice Committee of the American Society for Reproductive Medicine, 2003
Metabolic and Endocrine Agents · Insulin Sensitizing Agents
Metformin in polycystic ovary syndrome: systematic review and meta-analysis
Lord JM et al., 2003
Hormonal Agents · Gonadotropins
Use of recombinant human chorionic gonadotropin in ovulation induction
Ludwig M et al., 2003
Metabolic and Endocrine Agents · Insulin Sensitizing Agents
A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome
Costello MF et al., 2003
Hormonal Agents · Androgens and DHEA
Comparison of spironolactone and spironolactone plus finasteride in the treatment of hirsutism
Unlühizarci K K et al., 2002
